FAMily Oriented Support (FAMOS): Psychosocial Intervention for Childhood Cancer Survivors and Their Families

Childhood Cancer Clinical Trial

Official title:

FAMOS: The Effect of Psychosocial Intervention for Childhood Cancer Survivors and Their Families: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02200731
• Other study ID #: FAMOS
• Status: Completed
• Phase: N/A
• Start date: July 2014
• Est. completion date: November 2019

Study information

• Verified date: February 2021
• Source: Danish Cancer Society
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To investigate whether a home-based psychosocial family intervention that takes place shortly after ending the primary medical treatment can help families adjust to their cancer-related psychological issues.

Description:

The objective of this randomized controlled trial is to investigate whether home-based psychosocial interventions are able to help families of childhood cancer survivors cope with cancer-related psychological issues.

Method: 300 families will be recruited from the four pediatric oncology departments in Denmark where 150 families' will receive a home-based psychosocial intervention and 150 families will be in the control group. The study will take place shortly after the child completes the primary treatment. The primary outcome is post-traumatic stress symptoms (PTSS) in parents and secondary outcomes include among others quality of life, sick-leave, coping strategies and family functioning. Families in the intervention group will receive a 6 session manualized intervention based on a Cognitive Behavioral framework. Four sessions will focus on the parents and two sessions will focus on the child, who had cancer, and his/her siblings. The main goal of the sessions is to teach families how to adapt healthy psychological adjustments to pediatric oncology and prevent PTSS in family members. As a part of the intervention, families will be presented with video clips of other parents discussing how cancer has affected their family, to show common issues in experiencing having a child undergo cancer treatment. Every family member will be asked to complete a set of questionnaires to measure the outcome of the intervention at baseline before the intervention, 6 months follow-up and 12 months follow-up.

It is expected that families in the intervention group experience a larger improvement in their post-traumatic stress symptoms as well as strengthening the family function, quality of life and reducing sick leave compared to the control group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 185
• Est. completion date: November 2019
• Est. primary completion date: June 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A to 75 Years

Eligibility

Inclusion Criteria:

• Families of children in the age range of 0-17 years diagnosed with any kind of cancer and treated at one of the four pediatric oncology departments in Denmark are invited to participate in the project after ending primary medical treatment.

Exclusion Criteria:

• If the child has a severe co-morbidity

• If the child has a mental disorder at diagnosis

• If the child is declared terminal ill at the end of treatment (less than 6 months of survival).

• If the parents and the children do not speak Danish. The participants have to be able to read and answer the questionnaires at the least, to be included in the project.

• If the parents do not wish to hand in consent form

• If the family participates in another randomized psychosocial intervention project

Related Conditions & MeSH terms

• Childhood Cancer

Intervention

Behavioral:
• FAMOS: psychosocial family intervention
The FAMOS intervention consists of a six session manualized psychosocial intervention including videos and tools. Four sessions focus on the parents and two sessions focus on the childhood cancer survivor and its siblings. The intervention is conducted by a psychologist with Cognitive Behavioral Therapy experience

Locations

Country	Name	City	State
Denmark	Danish Cancer Society	Copenhagen

Sponsors (5)

Lead Sponsor	Collaborator
Pernille Bidstrup	Aarhus University Hospital, Aarhus University Hospital Skejby, Odense University Hospital, Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Post traumatic stress symptoms (PTSS) in parents measured by Harvard Trauma Questionnaire (HTQ)	A larger reduction in post traumatic stress symptoms amongst parents of childhood cancer survivors in the intervention group from baseline to 6 months follow up compared to parents in the control group	Baseline and 6 months
Secondary	Post traumatic stress symptoms (PTSS) in parents measured by Harvard Trauma Questionnaire (HTQ)	A larger reduction in post traumatic stress symptoms amongst parents of childhood cancer survivors in the intervention group from baseline to 12 months follow up versus parents in the control group	Baseline and 12 months
Secondary	Post traumatic stress symptoms (PTSS) in childhood cancer survivors and their siblings measured by Harvard Trauma Questionnaire (HTQ), Daryl or Pediatric Emotional Distress Scale (PEDS)	A larger reduction in PTSS from baseline to respectively 6 and 12 months follow up in childhood cancer survivors and their siblings the intervention group versus the control group measured by Harvard Trauma Questionnaire (HTQ), Daryl or Pediatric Emotional Distress Scale (PEDS)	Baseline, 6 months and 12 months
Secondary	Family psychosocial functioning measured by Psychological Assessment Tool 2.0 (PAT2.0) and Family Impact Module 2.0 (FIM2.0)	An larger enhancement in the family's' psychosocial functioning from baseline to 6 months follow up and 12 months follow up measured by Psychological Assessment Tool 2.0 (PAT2.0) and Family Impact Module 2.0 (FIM2.0) in the intervention group versus the control group.	Baseline, 6 months and 12 months
Secondary	Siblings perception measured by the Siblings Perception Questionnaire (SPQ)	A change in siblings' perception of how cancer affected their daily life from baseline to 6 months and 12 months follow-up measured by Sibling Perception Questionnaire (SPQ) in the intervention group versus the control group.	Baseline, 6 months and 12 months
Secondary	Quality of life measured by Pediatric Quality of Life (PedsQL)	An enhancement in quality of life in childhood cancer survivors, their siblings and parents from baseline to 6 month and 12 month follow-up measured by Pediatric Quality of Life (PedsQL) in the intervention group versus the control group	Baseline, 6 months and 12 months
Secondary	Self reported sick leave in parents	A larger reduction in sick leave for parents from baseline to 6 month and 12 month follow-up measured by self reporting in the intervention group versus the control group.	Baseline, 6 months and 12 months
Secondary	Less stress induced telomere shortening	A 10 ml blood sample to measure whether a psychosocial intervention results in a less shortening of the telomere length amongst parents of childhood cancer survivors from baseline to 12 months follow up versus parents in the control group	Baseline and 12 months
Secondary	Anxiety and depression in parents of childhood cancer survivors measured by the Symptom Checklist (SCL)	A larger reduction in anxiety and depression symptoms in parents of childhood cancer survivors in the intervention group from baseline to 6 and 12 months follow up compared to the control group	Baseline, 6 months and 12 months
Secondary	Anxiety and depression in siblings over 18 years of childhood cancer survivors measured by the Symptom Checklist (SCL)	A larger reduction in anxiety and depression symptoms in siblings over 18 years of childhood cancer survivors in the intervention group from baseline to 6 and 12 months follow up compared to the control group	Baseline, 6 months and 12 months
Secondary	Anxiety and depression in childhood cancer survivors and their siblings i the age range 8 to 17 years measured by the Revised Child Anxiety and Depression Scale (RCADS)	A larger reduction in anxiety and depression symptoms in childhood cancer survivors and their siblings i the age range 8 to 17 years in the intervention group from baseline to 6 and 12 months follow up compared to the control group	Baseline, 6 months and 12 months